Baseline bone mineral density testing among breast cancer patients prescribed aromatase inhibitors (AIs).

被引：0
|
作者：
Charlson, John A. [1 ]
Smith, Elizabeth [1 ]
Laud, Purushottam [1 ]
Smallwood, Alicia [1 ]
Neuner, Joan [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6642
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Katsuhiko Nakatsukasa
    Hiroshi Koyama
    Yoshimi Ouchi
    Kouichi Sakaguchi
    Yoshifumi Fujita
    Takayuki Matsuda
    Makoto Kato
    Eiichi Konishi
    Tetsuya Taguchi
    Journal of Bone and Mineral Metabolism, 2019, 37 : 301 - 306
  • [22] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Ouchi, Yoshimi
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Taguchi, Tetsuya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (02) : 301 - 306
  • [23] BONE MINERAL DENSITY AND MORPHOMETRIC VERTEBRAL DEFORMITIES IN POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS FOR BREAST CANCER
    Maldonado-Romero, L. V.
    Ahijon-Lana, M.
    Velazquez-Arce, C.
    Sifuentes Giraldo, W. A.
    Martinez Janez, N.
    Vazquez Diaz, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1201 - 1201
  • [24] Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density
    Nunes, Frederico Arthur Pereira
    de Farias, Maria Lucia Fleiuss
    Oliveira, Felipe Peres
    Neto, Leonardo Vieira
    Lima, Luis Felipe Cardoso
    Neto, Francisco de Paula Paranhos
    de Mendonca, Laura Maria Carvalho
    Madeira, Miguel
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (04): : 505 - 511
  • [25] AUDIT OF BREAST CANCER PATIENTS ON AROMATASE INHIBITORS WITH BASELINE DEXA SCANS
    Tanna, N.
    Batten, C.
    Pitkin, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S481 - S482
  • [26] EFFECT ON BONE MINERAL DENSITY OF ORAL BISPHOSPHONATES IN WOMEN WITH OSTEOPOROSIS AND BREAST CANCER TREATED WITH AROMATASE INHIBITORS: ARE BONE TURNOVER MARKERS USEFUL IN THESE PATIENTS?
    Vazquez, I.
    Casado, E.
    Larrosa, M.
    Dalmau, E.
    Segui, M. A.
    Gratacos, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 321 - 321
  • [27] BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Erdemci, B.
    Ayan, A. K.
    Uzkeser, H.
    Orsal, E.
    Ozmen, H. K.
    Karatay, S.
    Yildirim, K.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : 685 - 685
  • [28] Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer
    Nogues, Xavier
    Servitja, Sonia
    Jesus Pena, Maria
    Prieto-Alhambra, Daniel
    Nadal, Rosa
    Mellibovsky, Leonardo
    Albanell, Joan
    Diez-Perez, Adolfo
    Tusquets, Ignasi
    MATURITAS, 2010, 66 (03) : 291 - 297
  • [29] Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
    Kwan, Marilyn L.
    Lo, Joan C.
    Tang, Li
    Laurent, Cecile A.
    Roh, Janise M.
    Chandra, Malini
    Hahn, Theresa E.
    Hong, Chi-Chen
    Sucheston-Campbell, Lara
    Hershman, Dawn L.
    Quesenberry, Charles P., Jr.
    Ambrosone, Christine B.
    Kushi, Lawrence H.
    Yao, Song
    PLOS ONE, 2014, 9 (10):
  • [30] Impact of aromatase inhibitors on bone health in breast cancer patients
    Geisler, Jurgen
    Lonning, Per E.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (4-5): : 294 - 299
12345